Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2005 055 699.0 |
| 96 | EP file number | EAKZ | 10 18 1105.7 |
| 97 | EP publication number | EPN | 2298281 |
| 54 | Designation/title | TI | Infusions- und Injektionslösung enthaltend Levodopa |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/08 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/198 (2006.01), A61P 25/16 (2006.01) |
| 22 | DE application date | DAT | Jul 8, 2005 |
| 96 | EP application date | EAT | Jul 8, 2005 |
| 43 | Date of first publication | OT | Mar 23, 2011 |
| Date of publication of grant | PET | Apr 24, 2019 |
| 71/73 | Applicant/owner | INH | Dizlin Pharmaceuticals AB, Vimmerby, SE |
| 72 | Inventor | IN | Dizdar Segrell, Nil, 582 37, Linköping, SE |
| Address for service | | Dizlin Pharmaceuticals AB, 59822 Vimmerby, SE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| SE
0401842
Jul 12, 2004
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002298281
Searchable text:
EP000002298281
Original document:
EP000002298281B1
Searchable text:
EP000002298281B1 |
| 43 | Date of first publication | EVT | Mar 23, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | May 20, 2021
(Show all update days)(Hide all update days)- May 20, 2021; Mar 21, 2021; Apr 1, 2020; Mar 11, 2020; Aug 9, 2019; Jul 12, 2019; May 16, 2019; Apr 9, 2019; Apr 4, 2019; Aug 2, 2018; Feb 15, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
